Clinical Trial Update: Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) [Phase 3]

View source ↗

Summary

BAATAF, a Phase 3 anticoagulation trial for atrial fibrillation, has completed the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Atrial Fibrillation
• Cardiovascular Disease
• Cerebral Embolism and Thrombosis
• Cerebrovascular Disorders
• Heart Diseases
• Stroke
• Thrombophlebitis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Arrhythmia, Atrial Fibrillation | Phase 3 | Status: COMPLETED